FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 277 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TTRX Nasdaq Turn Therapeutics Inc. 2830
TVGN Nasdaq Tevogen Bio Holdings Inc. 2830
TXMD Nasdaq TherapeuticsMD, Inc. 2830
UCBJY Over the counter UCB SA 2830
UNCY Nasdaq Unicycive Therapeutics, Inc. 2830
UPC Nasdaq Universe Pharmaceuticals INC 2830
UTHR Nasdaq United Therapeutics Corporation 2830
VALN Nasdaq Valneva SE 2830
VERU Nasdaq Veru Inc. 2830
VICP Over the counter Vicapsys Life Sciences, Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VRNO Over the counter Verano Holdings Corp. 2830
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XAIR Nasdaq Beyond Air, Inc. 2830
XENE Nasdaq Xenon Pharmaceuticals Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
YCBD NYSE American cbdMD, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 277 of 277